Paradeep Phosphates IPO scrapes through on Day 3; issue subscribed 1.75x


The Rs 1,500-crore initial public offering (IPO) of Paradeep Phosphates managed to scrape through despite challenging market conditions.

The issue, which closed on Thursday, managed to garner 1.75 times subscription.

The retail investor portion of the issue was subscribed 1.37 times, high-networth individual (HNI) portion was covered 82 per cent and institutional investor category saw three times subscription.

Paradeep Phosphates is India’s second-largest private sector manufacturer of phosphatic fertilizers.


The company raised Rs 1,004 crore fresh capital through the and the remaining for secondary share sale. The price band for the issue was Rs 39-42 per share. At the top-end, the company is valued at Rs 3,421 crore.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.


As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard,

Digital Editor

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *